Luca Benatti Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

Luca Benatti is Director of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 8,111 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $154,109. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Luca Benatti Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2023	SELL Sale (or disposition) back to the issuer	$154,109 $19.0 p/Share	8,111 Reduced 100.0%	0 Common Stock
Nov 08 2023	SELL Disposition due to a tender of shares in a change of control transaction	$484,253 $19.0 p/Share	25,487 Reduced 100.0%	0 Common Stock
May 24 2023	BUY Grant, award, or other acquisition	-	8,111 Added 19.45%	33,598 Common Stock
May 25 2022	BUY Grant, award, or other acquisition	-	7,737 Added 23.29%	25,487 Common Stock
May 27 2021	BUY Grant, award, or other acquisition	-	7,029 Added 28.37%	17,750 Common Stock

Also insider at

CRTX

Cortexyme, Inc. Healthcare

Luca Benatti

Director

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICPT shares.

Notify only if

Value

Insider Trading

Get notified when an Intercept Pharmaceuticals, Inc. insider buys or sells ICPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to INTERCEPT PHARMACEUTICALS, INC.

Account